Predictors of Short and Long-Term Success of Electrical Cardioversion in Persistent Atrial Fibrillation
DOI:
https://doi.org/10.51253/pafmj.v76iSUPPL-1.13818Keywords:
Atrial Fibrillation, Electrocardiography, Electrical Cardioversion, Sinus Rhythm, Treatment Outcome.Abstract
Objective: To determine the predictors of short-term and long-term success of electrical cardioversion in persistent atrial fibrillation.
Study Design: Prospective longitudinal study.
Place and Duration of Study: Department of Cardiology, Electrophysiology Division, Armed Forces Institute of Cardiology & National Institute of Heart Diseases (AFIC-NIHD), Rawalpindi Pakistan, from Sep 2024 to Apr 2025.
Methodology: A total of 119 male and female patients aged 20 to 90 years diagnosed with persistent atrial fibrillation. Patients with valvular heart disease, prior history of electrical cardioversion, paroxysmal atrial fibrillation, and left atrial clot were excluded. Electrical cardioversion was performed, and short-term (sinus rhythm restoration after a week) and long-term (sinus rhythm restoration after three months) success was noted. Data analysis was carried out using Statistical Package for the Social Sciences (SPSS) version 26.
Results: The mean age of the participants was 55.95±11.46 years, and the mean Atrial Fibrillation (AF) duration was 12.63±3.72 days. Patients aged more than 50 years were 77(64.7%), and 72(60.5%) patients were male. Successful cardioversion was recorded in 104 patients (87.4%). Short-term and long-term success was recorded in 92(77.3%) and 80(67.2%) patients, respectively. Acute successful cardioversion was more frequent when performed by a consultant with more than 12 years of experience (91.0% versus 76.7%, p-value 0.041).
Conclusion: Electrical cardioversion was shown to be an effective and successful therapy for persistent atrial fibrillation. Although success rates inevitably declined over time, the promising early outcomes demonstrate that electrical cardioversion is a dependable first-line technique for restoring sinus rhythm.
Downloads
References
1. Shima N, Miyamoto K, Kato S, Yoshida T, Uchino S. Primary success of electrical cardioversion for new-onset atrial fibrillation and its association with clinical course in non-cardiac critically ill patients: sub-analysis of a multicenter observational study. J Intensive Care 2021; 9(1): 46.
https://doi.org/10.1186/s40560-021-00562-8
2. Yoshida T, Uchino S, Sasabuchi Y, Hagiwara Y. Prognostic impact of sustained new-onset atrial fibrillation in critically ill patients. Intensive Care Med 2020; 46(1): 27-35.
https://doi.org/10.1007/s00134-019-05822-8
3. Yoshida T, Uchino S, Sasabuchi Y. Clinical course after identification of new-onset atrial fibrillation in critically ill patients: The AFTER-ICU study. J Crit Care 2020; 59: 136-142.
https://doi.org/10.1016/j.jcrc.2020.06.014
4. Arrigo M, Jaeger N, Seifert B, Spahn DR, Bettex D, Rudiger A. Disappointing success of electrical cardioversion for new-onset atrial fibrillation in cardiosurgical ICU patients. Crit Care Med 2015; 43(11): 2354-2359.
https://doi.org/10.1097/CCM.0000000000001257
5. Hindricks G, Potpara T, Dagres N, Arbelo E, Bax JJ, Blomström-Lundqvist C, et al. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J 2021; 42(5): 373-498.
https://doi.org/10.1093/eurheartj/ehaa612
6. Klein Klouwenberg PM, Frencken JF, Kuipers S, Ong DS, Peelen LM, van Vught LA, et al. Incidence, predictors, and outcomes of new-onset atrial fibrillation in critically ill patients with sepsis: a cohort study. Am J Respir Crit Care Med 2017; 195(2): 205-211.
https://doi.org/10.1164/rccm.201603-0618OC
7. Brandes A, Crijns H, Rienstra M, Kirchhof P, Grove EL, Pedersen KB, et al. Cardioversion of atrial fibrillation and atrial flutter revisited: current evidence and practical guidance for a common procedure. Europace 2020; 22(8): 1149-1161.
https://doi.org/10.1093/europace/euaa057
8. Nguyen ST, Belley-Côté EP, Ibrahim O, Um KJ, Lengyel A, Adli T, et al. Techniques improving electrical cardioversion success for patients with atrial fibrillation: a systematic review and meta-analysis. Europace 2023; 25(2): 318-330.
https://doi.org/10.1093/europace/euac199
9. Vinter N, Holst-Hansen MZB, Johnsen SP, Lip GYH, Frost L, Trinquart L. Electrical energy by electrode placement for cardioversion of atrial fibrillation: a systematic review and meta-analysis. Open Heart 2023; 10(2): e002456.
https://doi.org/10.1136/openhrt-2023-002456
10. Kuppahally SS, Foster E, Shoor S, Steimle AE. Short-term and long-term success of electrical cardioversion in atrial fibrillation in managed care system. Int Arch Med 2009; 2: 39.
https://doi.org/10.1186/1755-7682-2-39
11. Huo Y, Gaspar T, Schönbauer R, Wójcik M, Fiedler L, Roithinger FX, et al. Low-voltage myocardium-guided ablation trial of persistent atrial fibrillation. NEJM Evid 2022; 1(11): EVIDoa2200141. https://doi.org/10.1056/EVIDoa2200141
12. Blum S, Aeschbacher S, Meyre P, Zwimpfer L, Reichlin T, Beer JH, et al. Incidence and predictors of atrial fibrillation progression. J Am Heart Assoc 2019; 8(20): e012554.
https://doi.org/10.1161/JAHA.119.012554
13. Nguyen BO, Weberndorfer V, Crijns HJ, Geelhoed B, Ten Cate H, Spronk H, et al. Prevalence and determinants of atrial fibrillation progression in paroxysmal atrial fibrillation. Heart 2022; 109(3): 186-194.
https://doi.org/10.1136/heartjnl-2022-321027
14. Frick M, Frykman V, Jensen-Urstad M, Ostergren J, Rosenqvist M. Factors predicting success rate and recurrence of atrial fibrillation after first electrical cardioversion in patients with persistent atrial fibrillation. Clin Cardiol 2001; 24(3): 238-244.
https://doi.org/10.1002/clc.4960240313
15. Blich M, Edoute Y. Electrical cardioversion for persistent or chronic atrial fibrillation: outcome and clinical factors predicting short and long term success rate. Int J Cardiol 2006; 107(3): 389-394. https://doi.org/10.1016/j.ijcard.2005.03.057
16. Toso E, Blandino A, Sardi D, Battaglia A, Garberoglio L, Miceli S, et al. Electrical cardioversion of persistent atrial fibrillation: acute and long-term results stratified according to arrhythmia duration. Pacing Clin Electrophysiol 2012; 35(9): 1126-1134.
https://doi.org/10.1111/j.1540-8159.2012.03453.x
17. Ebert M, Stegmann C, Kosiuk J, Dinov B, Richter S, Arya A, et al. Predictors, management, and outcome of cardioversion failure early after atrial fibrillation ablation. Europace 2018; 20(9): 1428-1434.
https://doi.org/10.1093/europace/eux327
18. Kang SH, Choi EK, Han KD, Lee SR, Lim WH, Cha MJ, et al. Underweight is a risk factor for atrial fibrillation: a nationwide population-based study. Int J Cardiol 2016; 215: 449-456.
https://doi.org/10.1016/j.ijcard.2016.04.036
19. Wang J, Yang YM, Zhu J, Zhang H, Shao XH, Tian L, et al. Overweight is associated with improved survival and outcomes in patients with atrial fibrillation. Clin Res Cardiol 2014; 103(7): 533-542.
https://doi.org/10.1007/s00392-014-0681-7
20. Hellman T, Kiviniemi T, Vasankari T, Nuotio I, Biancari F, Bah A, et al. Prediction of ineffective elective cardioversion of atrial fibrillation: a retrospective multi-center patient cohort study. BMC Cardiovasc Disord 2017; 17(1): 33.
https://doi.org/10.1186/s12872-017-0470-0
21. Zhao TX, Martin CA, Cooper JP, Gajendragadkar PR. Coarse fibrillatory waves in atrial fibrillation predict success of electrical cardioversion. Ann Noninvasive Electrocardiol 2018; 23(4): e12528.
https://doi.org/10.1111/anec.12528
22. Goette A, Honeycutt C, Langberg JJ. Electrical remodeling in atrial fibrillation. Time course and mechanisms. Circulation 1996; 94(11): 2968-2974.
Downloads
Published
License
Copyright (c) 2026 Hira Ahmad, Muhammad Shabbir , Huma Mushtaq, Shahid Mukarram, Tehreem Fahd, Syed Sajidain Syed
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
How to Cite
